首页 > 最新文献

Hemodialysis international. International Symposium on Home Hemodialysis最新文献

英文 中文
The effects of death anxiety on diet-fluid restriction non-adherence in hemodialysis patients. 死亡焦虑对血液透析患者不遵守饮食-液体限制的影响。
Gülcan Bahçecioğlu Turan, Zülfünaz Özer, Seda Başak

Introduction: The study was performed to examine the effects of death anxiety on diet-fluid restriction non-adherence in hemodialysis patients.

Methods: This descriptive, cross-sectional, and correlational study was performed with 118 hemodialysis patients who received treatment in the dialysis unit of a university hospital and a state hospital in Elazığ, eastern Turkey. The study data were obtained with the "Descriptive Data Form", "Death Anxiety Scale", and "Dietary and Fluid Restriction Non-Adherence Scale".

Findings: The average Death Anxiety Scale total score of the patients was 10.00 ± 4.75. The "Duration of non-adherence with diet" mean score was 1.66 ± 1.70, "Degree of non-adherence with diet" mean score was 1.24 ± 1.19, "Duration of non-adherence with fluid restriction" mean score was 1.61 ± 1.71, and "Degree of non-adherence with fluid restriction" mean score was 1.16 ± 1.13. The independent variable Death Anxiety Scale significantly and negatively affected the dependent variable "Duration of non-adherence with diet", "Degree of non-adherence with diet", "Duration of non-adherence with fluid restriction", and "Degree of non-adherence with fluid restriction".

Discussion: Hemodialysis patients face serious death anxiety, their degree of non-adherence with diet-fluid restriction was low as death anxiety scores increased, and the degree of non-adherence with diet-fluid restriction decreased.

简介:本研究旨在探讨死亡焦虑对血液透析患者不坚持饮食-液体限制的影响:本研究旨在探讨死亡焦虑对血液透析患者不遵守饮食-液体限制的影响:这项描述性、横断面和相关性研究的对象是在土耳其东部埃拉泽的一所大学医院和一所国立医院的透析室接受治疗的118名血液透析患者。研究数据通过 "描述性数据表"、"死亡焦虑量表 "和 "饮食和液体限制不遵守量表 "获得:患者的死亡焦虑量表总分平均为(10.00 ± 4.75)分。饮食不依从持续时间 "平均分为(1.66±1.70)分,"饮食不依从程度 "平均分为(1.24±1.19)分,"液体限制不依从持续时间 "平均分为(1.61±1.71)分,"液体限制不依从程度 "平均分为(1.16±1.13)分。自变量死亡焦虑量表对因变量 "不坚持饮食的持续时间"、"不坚持饮食的程度"、"不坚持限制输液的持续时间 "和 "不坚持限制输液的程度 "有明显的负向影响:讨论:血液透析患者面临严重的死亡焦虑,随着死亡焦虑评分的增加,他们不坚持限制饮食和液体的程度较低,而不坚持限制饮食和液体的程度降低。
{"title":"The effects of death anxiety on diet-fluid restriction non-adherence in hemodialysis patients.","authors":"Gülcan Bahçecioğlu Turan, Zülfünaz Özer, Seda Başak","doi":"10.1111/hdi.13191","DOIUrl":"https://doi.org/10.1111/hdi.13191","url":null,"abstract":"<p><strong>Introduction: </strong>The study was performed to examine the effects of death anxiety on diet-fluid restriction non-adherence in hemodialysis patients.</p><p><strong>Methods: </strong>This descriptive, cross-sectional, and correlational study was performed with 118 hemodialysis patients who received treatment in the dialysis unit of a university hospital and a state hospital in Elazığ, eastern Turkey. The study data were obtained with the \"Descriptive Data Form\", \"Death Anxiety Scale\", and \"Dietary and Fluid Restriction Non-Adherence Scale\".</p><p><strong>Findings: </strong>The average Death Anxiety Scale total score of the patients was 10.00 ± 4.75. The \"Duration of non-adherence with diet\" mean score was 1.66 ± 1.70, \"Degree of non-adherence with diet\" mean score was 1.24 ± 1.19, \"Duration of non-adherence with fluid restriction\" mean score was 1.61 ± 1.71, and \"Degree of non-adherence with fluid restriction\" mean score was 1.16 ± 1.13. The independent variable Death Anxiety Scale significantly and negatively affected the dependent variable \"Duration of non-adherence with diet\", \"Degree of non-adherence with diet\", \"Duration of non-adherence with fluid restriction\", and \"Degree of non-adherence with fluid restriction\".</p><p><strong>Discussion: </strong>Hemodialysis patients face serious death anxiety, their degree of non-adherence with diet-fluid restriction was low as death anxiety scores increased, and the degree of non-adherence with diet-fluid restriction decreased.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of using a local skin cooling device on arteriovenous fistula cannulation pain and comfort level of patients on hemodialysis: A single-blind randomized controlled study. 使用局部皮肤冷却装置对血液透析患者动静脉内瘘插管疼痛和舒适度的影响:单盲随机对照研究。
Hatice Demırağ, Nurşen Kulakaç

Introduction: The study aimed to investigate the impact of the using local skin cooling on arteriovenous fistula cannulation pain and the comfort levels of hemodialysis patients.

Methods: The single-blind randomized controlled trial was formed with 50 patients between June 20, 2023, and July 31, 2023, in the hemodialysis units of two state hospitals in Turkey. Patients were randomly assigned to either the experimental group (n = 25) or the control group (n = 25) using the block randomization method. This data were collected through the use of the CoolSense device, the "Patient Information Form," the "Verbal Category Scale," and the "General Comfort Scale." Patients in the experimental group received the local skin cooling for five seconds during arteriovenous fistula cannulation, while the control group followed the standard hospital protocol. The study was registered on Clinical Trials (NCT06144801).

Findings: The study revealed that the application of the local skin cooling during arteriovenous fistula cannulation significantly reduced pain and increased patients' comfort levels, demonstrating an anesthetic effect (p < 0.001). Furthermore, it was observed that as pain levels decreased, patient comfort levels increased (p < 0.001).

Discussion: It is concluded that the using lokal skin cooling is an effective tool for reducing pain and enhancing comfort during arteriovenous fistula cannulation in hemodialysis patients.

简介:该研究旨在探讨局部皮肤冷却对动静脉内瘘插管疼痛和血液透析患者舒适度的影响:该研究旨在探讨局部皮肤冷却对动静脉内瘘插管疼痛和血液透析患者舒适度的影响:在 2023 年 6 月 20 日至 7 月 31 日期间,在土耳其两家国立医院的血液透析室对 50 名患者进行了单盲随机对照试验。采用分块随机法将患者随机分配到实验组(25 人)或对照组(25 人)。这些数据是通过使用 CoolSense 设备、"患者信息表"、"口头分类量表 "和 "一般舒适度量表 "收集的。实验组患者在动静脉内瘘插管过程中接受了 5 秒钟的局部皮肤冷却,而对照组则按照医院的标准方案进行。该研究已在临床试验(NCT06144801)上注册:研究结果表明,在动静脉内瘘插管时应用局部皮肤冷却可明显减轻疼痛,提高患者的舒适度,显示出麻醉效果(P 讨论):结论:在血液透析患者动静脉内瘘插管期间,使用局部皮肤冷却是减轻疼痛和提高舒适度的有效工具。
{"title":"The effect of using a local skin cooling device on arteriovenous fistula cannulation pain and comfort level of patients on hemodialysis: A single-blind randomized controlled study.","authors":"Hatice Demırağ, Nurşen Kulakaç","doi":"10.1111/hdi.13190","DOIUrl":"https://doi.org/10.1111/hdi.13190","url":null,"abstract":"<p><strong>Introduction: </strong>The study aimed to investigate the impact of the using local skin cooling on arteriovenous fistula cannulation pain and the comfort levels of hemodialysis patients.</p><p><strong>Methods: </strong>The single-blind randomized controlled trial was formed with 50 patients between June 20, 2023, and July 31, 2023, in the hemodialysis units of two state hospitals in Turkey. Patients were randomly assigned to either the experimental group (n = 25) or the control group (n = 25) using the block randomization method. This data were collected through the use of the CoolSense device, the \"Patient Information Form,\" the \"Verbal Category Scale,\" and the \"General Comfort Scale.\" Patients in the experimental group received the local skin cooling for five seconds during arteriovenous fistula cannulation, while the control group followed the standard hospital protocol. The study was registered on Clinical Trials (NCT06144801).</p><p><strong>Findings: </strong>The study revealed that the application of the local skin cooling during arteriovenous fistula cannulation significantly reduced pain and increased patients' comfort levels, demonstrating an anesthetic effect (p < 0.001). Furthermore, it was observed that as pain levels decreased, patient comfort levels increased (p < 0.001).</p><p><strong>Discussion: </strong>It is concluded that the using lokal skin cooling is an effective tool for reducing pain and enhancing comfort during arteriovenous fistula cannulation in hemodialysis patients.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prior central venous catheter placement and age are associated with earlier intervention after permanent hemodialysis access creation. 在建立永久性血液透析通路后,先前的中心静脉导管置入和年龄与较早进行干预有关。
Ramtin Talebi, Ramin Talebi, Joshua Chen, Angela Yang, Sanath Patil, Paul J DiMuzio, Babak Abai, Dawn M Salvatore, Michael J Nooromid

Introduction: Arteriovenous fistulas (AVFs) and grafts are essential for long-term hemodialysis access in patients with end-stage renal disease. However, complications and access failure often necessitate re-intervention. In this study, we aim to delineate the factors associated with earlier failure of permanent hemodialysis access warranting revision procedures.

Methods: This retrospective study aimed to identify factors associated with increased revision rates in AVFs and arteriovenous grafts, using multivariate survival analysis. A cohort of 136 patients who underwent initial arteriovenous access creation between 2005 and 2022 was analyzed. Patient characteristics, including age, comorbidities, access type, and vascular anatomy, were extracted, and hazard ratios (HR) were calculated to identify independent predictors of needing revision.

Findings: A total of 119 patients were included in the final cohort, with a mean age of 55.2 years. Over 40% of patients had a previous central venous catheter placement, while 15% had a previous AVF. The majority of procedures were performed on the left side (74%), and brachiocephalic fistulas were most commonly created (41%). Univariate and multivariate Cox regression revealed that age (adjusted HR = 1.02, p = 0.01) and prior central venous catheter placement (adjusted HR = 1.77, p = 0.01) were independent predictors of earlier revision, while other variables such as sex, hypertension, and diabetes did not show significant associations. Patients with prior central venous catheter placement had a 77% increased risk of revision, even when adjusted for confounders.

Discussion: Understanding predictors of successful long-term access outcomes can guide decision-making regarding access type and alternative strategies. In our cohort, increased age and prior central venous catheter placement are associated with a shorter time to failure of permanent hemodialysis access and an increased risk of needing revision.

导言:动静脉瘘(AVF)和移植物是终末期肾病患者进行长期血液透析的重要通路。然而,并发症和通路失效往往需要再次介入治疗。在这项研究中,我们旨在明确与永久性血液透析通路早期失败相关的因素,从而为翻修手术提供依据:这项回顾性研究旨在通过多变量生存分析,确定与动静脉滤过和动静脉移植物翻修率增加相关的因素。研究分析了 2005 年至 2022 年间接受初次动静脉通路创建的 136 名患者。研究人员提取了患者的特征,包括年龄、合并症、通路类型和血管解剖结构,并计算了危险比(HR),以确定需要翻修的独立预测因素:共有119名患者被纳入最终队列,平均年龄为55.2岁。超过 40% 的患者曾置入过中心静脉导管,15% 的患者曾置入过 AVF。大部分手术在左侧进行(74%),肱脑瘘最常见(41%)。单变量和多变量 Cox 回归显示,年龄(调整后 HR = 1.02,P = 0.01)和曾置入中心静脉导管(调整后 HR = 1.77,P = 0.01)是提前翻修的独立预测因素,而性别、高血压和糖尿病等其他变量与之无显著关联。即使对混杂因素进行调整,曾置入中心静脉导管的患者翻修风险也增加了77%:讨论:了解成功的长期入路结果的预测因素可为入路类型和替代策略的决策提供指导。在我们的队列中,年龄的增加和曾置入中心静脉导管与永久性血液透析通路失败的时间缩短和需要翻修的风险增加有关。
{"title":"Prior central venous catheter placement and age are associated with earlier intervention after permanent hemodialysis access creation.","authors":"Ramtin Talebi, Ramin Talebi, Joshua Chen, Angela Yang, Sanath Patil, Paul J DiMuzio, Babak Abai, Dawn M Salvatore, Michael J Nooromid","doi":"10.1111/hdi.13180","DOIUrl":"https://doi.org/10.1111/hdi.13180","url":null,"abstract":"<p><strong>Introduction: </strong>Arteriovenous fistulas (AVFs) and grafts are essential for long-term hemodialysis access in patients with end-stage renal disease. However, complications and access failure often necessitate re-intervention. In this study, we aim to delineate the factors associated with earlier failure of permanent hemodialysis access warranting revision procedures.</p><p><strong>Methods: </strong>This retrospective study aimed to identify factors associated with increased revision rates in AVFs and arteriovenous grafts, using multivariate survival analysis. A cohort of 136 patients who underwent initial arteriovenous access creation between 2005 and 2022 was analyzed. Patient characteristics, including age, comorbidities, access type, and vascular anatomy, were extracted, and hazard ratios (HR) were calculated to identify independent predictors of needing revision.</p><p><strong>Findings: </strong>A total of 119 patients were included in the final cohort, with a mean age of 55.2 years. Over 40% of patients had a previous central venous catheter placement, while 15% had a previous AVF. The majority of procedures were performed on the left side (74%), and brachiocephalic fistulas were most commonly created (41%). Univariate and multivariate Cox regression revealed that age (adjusted HR = 1.02, p = 0.01) and prior central venous catheter placement (adjusted HR = 1.77, p = 0.01) were independent predictors of earlier revision, while other variables such as sex, hypertension, and diabetes did not show significant associations. Patients with prior central venous catheter placement had a 77% increased risk of revision, even when adjusted for confounders.</p><p><strong>Discussion: </strong>Understanding predictors of successful long-term access outcomes can guide decision-making regarding access type and alternative strategies. In our cohort, increased age and prior central venous catheter placement are associated with a shorter time to failure of permanent hemodialysis access and an increased risk of needing revision.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between trace elements and cognitive function among hemodialysis patients in Turkey. 土耳其血液透析患者体内微量元素与认知功能之间的关系。
Meric Oruc, Furkan Asan, Selda Mercan, Sennur Kose, Mehmet Murat Kirpinar, Burc Cagri Poyraz, Sinan Trabulus, Feray Karaali Savrun, Mehmet Riza Altiparmak

Introduction: Cognitive impairment is common among patients with hemodialysis. Hemodialysis patients have theoretical risks for both deficiency and accumulation of trace elements. We aimed to investigate the relationship between cognitive dysfunction and whole blood levels of trace elements in hemodialysis patients. We also aimed to examine the effect of baseline trace element status and cognitive dysfunction on mortality.

Methods: Maintenance hemodialysis patients and age-and sex-matched controls were included. The whole blood levels of trace elements were measured by inductively coupled plasma mass spectrometry. Cognitive impairment was defined as a score of ≤24 points on the Montreal Cognitive Assessment test. Executive dysfunction was also defined as Trails A score of more than 75 s and Trails B score of more than 180 s.

Findings: Forty-two patients and 35 controls were included. Cognitive impairment was detected in 69% of the patients and 45.7% of the controls (p = 0.039). Cognitively impaired patients had lower education years (p = 0.003) and higher whole blood levels of manganese (Mn) and lead (Pb) (p = 0.026, p = 0.019, respectively) compared to patients without cognitive impairment. Mn levels were also found statistically higher in patients with executive dysfunction compared to patients without executive dysfunction (p = 0.005). Lower education years and higher Pb levels were independent risk factors for cognitive impairment in hemodialysis patients (odds ratio [OR] 0.589 [95% confidence interval, CI 0.400-0.866, p = 0.007] and OR 1.047 [95% CI 1.001-1.096, p = 0.047, respectively]).

Discussion: Cognitive impairment, especially impaired executive function, is common among patients with hemodialysis patients. Cognitive impairment is not found to be associated in cross-sectional analysis with several modifiable end-stage renal disease- and dialysis-associated factors. The accumulation of trace elements especially Mn and Pb might exacerbate the cognitive dysfunction in hemodialysis patients.

介绍:认知障碍在血液透析患者中很常见。理论上,血液透析患者存在微量元素缺乏和蓄积的风险。我们旨在研究血液透析患者认知功能障碍与全血微量元素水平之间的关系。我们还旨在研究基线微量元素状态和认知功能障碍对死亡率的影响:方法:纳入维持性血液透析患者和年龄与性别匹配的对照组。采用电感耦合等离子体质谱法测量了全血中的微量元素水平。认知障碍的定义是蒙特利尔认知评估测试得分≤24分。执行功能障碍还被定义为 Trails A 评分超过 75 秒,Trails B 评分超过 180 秒:共纳入 42 名患者和 35 名对照组患者。69%的患者和 45.7% 的对照组发现了认知障碍(P = 0.039)。与无认知障碍的患者相比,认知障碍患者受教育年限较低(p = 0.003),全血锰(Mn)和铅(Pb)水平较高(分别为 p = 0.026 和 p = 0.019)。与无执行功能障碍的患者相比,执行功能障碍患者的锰含量在统计学上也更高(p = 0.005)。教育年限较低和铅含量较高是血液透析患者认知障碍的独立风险因素(几率比[OR]分别为0.589[95%置信区间,CI 0.400-0.866,p = 0.007]和OR 1.047 [95% CI 1.001-1.096,p = 0.047]):讨论:认知障碍,尤其是执行功能受损,在血液透析患者中很常见。在横断面分析中,未发现认知障碍与几种可改变的终末期肾病和透析相关因素有关。微量元素尤其是锰和铅的积累可能会加重血液透析患者的认知功能障碍。
{"title":"Association between trace elements and cognitive function among hemodialysis patients in Turkey.","authors":"Meric Oruc, Furkan Asan, Selda Mercan, Sennur Kose, Mehmet Murat Kirpinar, Burc Cagri Poyraz, Sinan Trabulus, Feray Karaali Savrun, Mehmet Riza Altiparmak","doi":"10.1111/hdi.13188","DOIUrl":"https://doi.org/10.1111/hdi.13188","url":null,"abstract":"<p><strong>Introduction: </strong>Cognitive impairment is common among patients with hemodialysis. Hemodialysis patients have theoretical risks for both deficiency and accumulation of trace elements. We aimed to investigate the relationship between cognitive dysfunction and whole blood levels of trace elements in hemodialysis patients. We also aimed to examine the effect of baseline trace element status and cognitive dysfunction on mortality.</p><p><strong>Methods: </strong>Maintenance hemodialysis patients and age-and sex-matched controls were included. The whole blood levels of trace elements were measured by inductively coupled plasma mass spectrometry. Cognitive impairment was defined as a score of ≤24 points on the Montreal Cognitive Assessment test. Executive dysfunction was also defined as Trails A score of more than 75 s and Trails B score of more than 180 s.</p><p><strong>Findings: </strong>Forty-two patients and 35 controls were included. Cognitive impairment was detected in 69% of the patients and 45.7% of the controls (p = 0.039). Cognitively impaired patients had lower education years (p = 0.003) and higher whole blood levels of manganese (Mn) and lead (Pb) (p = 0.026, p = 0.019, respectively) compared to patients without cognitive impairment. Mn levels were also found statistically higher in patients with executive dysfunction compared to patients without executive dysfunction (p = 0.005). Lower education years and higher Pb levels were independent risk factors for cognitive impairment in hemodialysis patients (odds ratio [OR] 0.589 [95% confidence interval, CI 0.400-0.866, p = 0.007] and OR 1.047 [95% CI 1.001-1.096, p = 0.047, respectively]).</p><p><strong>Discussion: </strong>Cognitive impairment, especially impaired executive function, is common among patients with hemodialysis patients. Cognitive impairment is not found to be associated in cross-sectional analysis with several modifiable end-stage renal disease- and dialysis-associated factors. The accumulation of trace elements especially Mn and Pb might exacerbate the cognitive dysfunction in hemodialysis patients.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing use of an electronic medical record system for quality improvement initiatives in hemodialysis: Review of a single center experience. 优化使用电子病历系统,提高血液透析质量:回顾单个中心的经验。
Noémie Laurier, Jorane-Tiana Robert, Alexander Tom, Jerrica McKinnon, Nancy Filteau, Laura Horowitz, Murray Vasilevsky, Catherine Weber, Tiina Podymow, Andrey V Cybulsky, Rita S Suri, Emilie Trinh

Introduction: The complexity of managing patients with end-stage kidney disease on hemodialysis underscores the importance of implementing quality improvement (QI) initiatives to enhance patient safety and prioritize patient-centered care. To address this, we established a QI committee at our tertiary academic center focusing on evidence-based practices, patient-centered approaches, and cost efficiency. To facilitate the seamless implementation of QI initiatives, we leveraged the capabilities of our electronic medical record (EMR) system.

Methods: This review details effective strategies for optimizing use of an EMR system to successfully implement QI efforts. Drawing from our experience, we provide detailed descriptions and practical insights that can be applied to other EMRs.

Findings: The creation of a secure and accessible dashboard, offering real-time data on quality metrics, stands out as the most notable feature. This dashboard operates through an algorithm that merges data from both our dialysis and hospital EMR systems. Its primary objectives are to streamline the identification of high-priority patients, enhance team communication, and facilitate tracking of quality indicators. Additionally, we integrated clinical pathways, checklists, and standardized protocols into the renal EMR to ensure smooth implementation of QI interventions. Notable examples of these interventions include an incremental hemodialysis protocol, a new hemodialysis start checklist, vaccination care plans, and personalized kidney transplant workups. Programmed electronic automatic reminders have proven invaluable in ensuring timely follow-ups of assigned tasks. The EMR has also contributed to medication optimization and deprescribing by generating patient lists based on specific medication classes. Finally, the EMR's capability to swiftly generate lists of patients with specific features has significantly facilitated targeted QI interventions.

Conclusions: Leveraging the capabilities of an EMR system can be crucial for enhancing care of hemodialysis patients and implementing effective QI initiatives.

导言:血液透析终末期肾病患者管理的复杂性凸显了实施质量改进(QI)计划以提高患者安全和优先考虑以患者为中心的护理的重要性。为此,我们在三级学术中心成立了质量改进委员会,重点关注循证实践、以患者为中心的方法和成本效益。为了促进 QI 计划的顺利实施,我们充分利用了电子病历系统(EMR)的功能:本综述详细介绍了优化使用 EMR 系统以成功实施 QI 的有效策略。根据我们的经验,我们提供了可应用于其他 EMR 的详细描述和实用见解:创建一个安全、可访问的仪表板,提供有关质量指标的实时数据,是最显著的特点。该仪表板通过一种算法,将透析和医院 EMR 系统中的数据合并在一起。它的主要目的是简化高优先级患者的识别,加强团队沟通,促进质量指标的跟踪。此外,我们还将临床路径、核对表和标准化协议整合到肾脏 EMR 中,以确保质量改进干预措施的顺利实施。这些干预措施的显著例子包括增量血液透析方案、新的血液透析启动核对表、疫苗接种护理计划和个性化肾移植工作检查。事实证明,程序化的电子自动提醒在确保及时跟进指定任务方面非常有价值。此外,电子医疗记录仪还能根据特定药物类别生成病人名单,从而有助于优化用药和取消处方。最后,EMR 能够迅速生成具有特定特征的病人名单,这极大地促进了有针对性的 QI 干预:利用电子病历系统的功能对于加强血液透析患者的护理和实施有效的质量改进措施至关重要。
{"title":"Optimizing use of an electronic medical record system for quality improvement initiatives in hemodialysis: Review of a single center experience.","authors":"Noémie Laurier, Jorane-Tiana Robert, Alexander Tom, Jerrica McKinnon, Nancy Filteau, Laura Horowitz, Murray Vasilevsky, Catherine Weber, Tiina Podymow, Andrey V Cybulsky, Rita S Suri, Emilie Trinh","doi":"10.1111/hdi.13178","DOIUrl":"https://doi.org/10.1111/hdi.13178","url":null,"abstract":"<p><strong>Introduction: </strong>The complexity of managing patients with end-stage kidney disease on hemodialysis underscores the importance of implementing quality improvement (QI) initiatives to enhance patient safety and prioritize patient-centered care. To address this, we established a QI committee at our tertiary academic center focusing on evidence-based practices, patient-centered approaches, and cost efficiency. To facilitate the seamless implementation of QI initiatives, we leveraged the capabilities of our electronic medical record (EMR) system.</p><p><strong>Methods: </strong>This review details effective strategies for optimizing use of an EMR system to successfully implement QI efforts. Drawing from our experience, we provide detailed descriptions and practical insights that can be applied to other EMRs.</p><p><strong>Findings: </strong>The creation of a secure and accessible dashboard, offering real-time data on quality metrics, stands out as the most notable feature. This dashboard operates through an algorithm that merges data from both our dialysis and hospital EMR systems. Its primary objectives are to streamline the identification of high-priority patients, enhance team communication, and facilitate tracking of quality indicators. Additionally, we integrated clinical pathways, checklists, and standardized protocols into the renal EMR to ensure smooth implementation of QI interventions. Notable examples of these interventions include an incremental hemodialysis protocol, a new hemodialysis start checklist, vaccination care plans, and personalized kidney transplant workups. Programmed electronic automatic reminders have proven invaluable in ensuring timely follow-ups of assigned tasks. The EMR has also contributed to medication optimization and deprescribing by generating patient lists based on specific medication classes. Finally, the EMR's capability to swiftly generate lists of patients with specific features has significantly facilitated targeted QI interventions.</p><p><strong>Conclusions: </strong>Leveraging the capabilities of an EMR system can be crucial for enhancing care of hemodialysis patients and implementing effective QI initiatives.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta-analysis. 蔗糖铁氧氢氧化物与碳酸司维拉姆的疗效和安全性对比:系统回顾和荟萃分析。
Christos Georgopoulos, Anila Duni, Eleni Stamellou, Athanasios Kitsos, Charikleia Gouva, Evangelia Dounousi

Introduction: Phosphate binders are commonly used in patients receiving kidney replacement therapy (KRT), aiming to reduce and maintain serum phosphorus. Chronic kidney disease-mineral and bone disorder has been linked to reduced lifespan and worsened quality of life. This study aims to examine the efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate in patients receiving KRT.

Methods: The data sources examined were MEDLINE (PubMed), Scopus, and the Cochrane Central Register of Controlled Clinical Trials with a search deadline of October 2023. We examined randomized controlled trials that compared sucroferric oxyhydroxide versus sevelamer carbonate in the adult population receiving KRT. We performed a meta-analysis combining the data from trials, using R-studio.

Findings: Inclusion criteria were met by five randomized trials. There was no statistically significant difference in the reduction of serum phosphorus between the two groups (MD: -0.07 mmol/L, 95% CI-random effects: -0.15 to 0.02). In the same line, a non-statistically significant difference was observed in serum i-PTH reduction between the two drugs (MD = -1.53 mg/dL, 95% CI = (-4.45, 1.4), p = 0.26, random effects model). No statistically significant difference was observed in all adverse events between the two groups (odds ratio: 1.11, 95% CI: 0.65-1.88, random effects model). Further analysis of gastrointestinal adverse events revealed that sevelamer carbonate increases gastrointestinal adverse events by up to 60% (odds ratio: 1.60, 95% CI: 1.31-1.97, common (fixed) effect model).

Discussion: This meta-analysis of randomized trials showed that both drugs, sucroferric oxyhydroxide and sevelamer equally and effectively controlled serum phosphorus levels, whereas sucroferric oxyhydroxide revealed a better profile in terms of gastrointestinal adverse events. Sucroferric oxyhydroxide is a valuable option for patients receiving KRT when sevelamer carbonate is more difficult to tolerate.

简介:磷酸盐结合剂常用于接受肾脏替代疗法(KRT)的患者,旨在降低和维持血清磷。慢性肾病-矿物质和骨骼紊乱与寿命缩短和生活质量下降有关。本研究旨在探讨蔗糖铁氧氢氧化物与碳酸司维拉姆在接受 KRT 治疗的患者中的疗效和安全性:研究数据来源于 MEDLINE (PubMed)、Scopus 和 Cochrane Central Register of Controlled Clinical Trials,搜索截止日期为 2023 年 10 月。我们研究了在接受 KRT 的成人中比较蔗糖铁氧氢氧化物与碳酸司维拉姆的随机对照试验。我们使用 R-studio.Findings 对试验数据进行了荟萃分析:五项随机试验均符合纳入标准。两组试验在降低血清磷方面无统计学差异(MD:-0.07 mmol/L,95% CI-随机效应:-0.15 至 0.02)。同样,观察到两种药物在降低血清 i-PTH 方面存在无统计学意义的差异(MD = -1.53 mg/dL,95% CI = (-4.45, 1.4),p = 0.26,随机效应模型)。在所有不良事件中,两组之间未观察到有统计学意义的差异(几率比:1.11,95% CI:0.65-1.88,随机效应模型)。对胃肠道不良事件的进一步分析显示,碳酸司维拉默会使胃肠道不良事件增加多达60%(几率比:1.60,95% CI:1.31-1.97,共同(固定)效应模型):这项随机试验的荟萃分析表明,蔗糖铁氧氢氧化物和西维拉姆这两种药物都能同样有效地控制血清磷水平,而蔗糖铁氧氢氧化物在胃肠道不良事件方面的表现更好。在碳酸司维拉姆较难耐受的情况下,蔗糖铁氧氢氧化物是接受 KRT 的患者的重要选择。
{"title":"Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta-analysis.","authors":"Christos Georgopoulos, Anila Duni, Eleni Stamellou, Athanasios Kitsos, Charikleia Gouva, Evangelia Dounousi","doi":"10.1111/hdi.13187","DOIUrl":"https://doi.org/10.1111/hdi.13187","url":null,"abstract":"<p><strong>Introduction: </strong>Phosphate binders are commonly used in patients receiving kidney replacement therapy (KRT), aiming to reduce and maintain serum phosphorus. Chronic kidney disease-mineral and bone disorder has been linked to reduced lifespan and worsened quality of life. This study aims to examine the efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate in patients receiving KRT.</p><p><strong>Methods: </strong>The data sources examined were MEDLINE (PubMed), Scopus, and the Cochrane Central Register of Controlled Clinical Trials with a search deadline of October 2023. We examined randomized controlled trials that compared sucroferric oxyhydroxide versus sevelamer carbonate in the adult population receiving KRT. We performed a meta-analysis combining the data from trials, using R-studio.</p><p><strong>Findings: </strong>Inclusion criteria were met by five randomized trials. There was no statistically significant difference in the reduction of serum phosphorus between the two groups (MD: -0.07 mmol/L, 95% CI-random effects: -0.15 to 0.02). In the same line, a non-statistically significant difference was observed in serum i-PTH reduction between the two drugs (MD = -1.53 mg/dL, 95% CI = (-4.45, 1.4), p = 0.26, random effects model). No statistically significant difference was observed in all adverse events between the two groups (odds ratio: 1.11, 95% CI: 0.65-1.88, random effects model). Further analysis of gastrointestinal adverse events revealed that sevelamer carbonate increases gastrointestinal adverse events by up to 60% (odds ratio: 1.60, 95% CI: 1.31-1.97, common (fixed) effect model).</p><p><strong>Discussion: </strong>This meta-analysis of randomized trials showed that both drugs, sucroferric oxyhydroxide and sevelamer equally and effectively controlled serum phosphorus levels, whereas sucroferric oxyhydroxide revealed a better profile in terms of gastrointestinal adverse events. Sucroferric oxyhydroxide is a valuable option for patients receiving KRT when sevelamer carbonate is more difficult to tolerate.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of a patient with inoperable tumoral calcinosis associated with end stage kidney disease: A case report. 治疗一名无法手术的肿瘤性钙化伴终末期肾病患者:病例报告。
Sarah K Couser, Donna J Claes, Sydney Huesman, David K Hooper

We describe a case of severe symptomatic tumoral calcinosis in a young man with end stage kidney disease secondary to antineutrophil cytoplasmic antibodies-associated vasculitis with longstanding hyperphosphatemia and secondary hyperparathyroidism while on several years of peritoneal dialysis. The use of intravenous sodium thiosulfate, optimization of clearance with five times weekly hemodialysis, and intradialytic nutrition were used to treat his inoperable tumoral calcinosis. Over 3 months, he had a remarkable reduction in the size of his calcified masses and associated improvement in pain. He subsequently received a living donor kidney transplant.

我们描述了一例严重的无症状肿瘤性钙化病例,患者是一名年轻男性,因抗中性粒细胞胞浆抗体相关性血管炎继发终末期肾病,并伴有长期高磷血症和继发性甲状旁腺功能亢进,同时已接受腹膜透析数年。为了治疗无法手术的肿瘤性钙化症,他使用了静脉注射硫代硫酸钠、每周五次的血液透析优化清除率以及透析内营养。3 个月后,他的钙化肿块明显缩小,疼痛也有所改善。随后,他接受了活体肾移植。
{"title":"Treatment of a patient with inoperable tumoral calcinosis associated with end stage kidney disease: A case report.","authors":"Sarah K Couser, Donna J Claes, Sydney Huesman, David K Hooper","doi":"10.1111/hdi.13179","DOIUrl":"https://doi.org/10.1111/hdi.13179","url":null,"abstract":"<p><p>We describe a case of severe symptomatic tumoral calcinosis in a young man with end stage kidney disease secondary to antineutrophil cytoplasmic antibodies-associated vasculitis with longstanding hyperphosphatemia and secondary hyperparathyroidism while on several years of peritoneal dialysis. The use of intravenous sodium thiosulfate, optimization of clearance with five times weekly hemodialysis, and intradialytic nutrition were used to treat his inoperable tumoral calcinosis. Over 3 months, he had a remarkable reduction in the size of his calcified masses and associated improvement in pain. He subsequently received a living donor kidney transplant.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plaque psoriasis with renal dysfunction successfully treated with ixekizumab. 使用ixekizumab成功治疗伴有肾功能障碍的斑块状银屑病。
Xinyu Zhu, Xiaoyuan Pan, Zhengbang Dong

Psoriasis is an immune-mediated chronic inflammatory skin disease and chronic kidney disease is one of the common comorbidities of psoriasis. Ixekizumab, a humanized IgG4 monoclonal antibody, has been approved for the treatment of moderate-to-severe plaque psoriasis in recent years. However, ixekizumab has not been studied in a population of patients with renal insufficiency. We report two cases of plaque psoriasis patients with renal dysfunction successfully treated with ixekizumab without dose reduction,which experience no side effects and does not cause further kidney injury.

银屑病是一种免疫介导的慢性炎症性皮肤病,慢性肾病是银屑病的常见并发症之一。Ixekizumab 是一种人源化 IgG4 单克隆抗体,近年来已被批准用于治疗中重度斑块状银屑病。然而,ixekizumab尚未在肾功能不全的患者群体中进行过研究。我们报告了两例肾功能不全的斑块状银屑病患者,他们成功地使用了ixekizumab,而且没有减少剂量,既没有副作用,也不会造成进一步的肾损伤。
{"title":"Plaque psoriasis with renal dysfunction successfully treated with ixekizumab.","authors":"Xinyu Zhu, Xiaoyuan Pan, Zhengbang Dong","doi":"10.1111/hdi.13185","DOIUrl":"https://doi.org/10.1111/hdi.13185","url":null,"abstract":"<p><p>Psoriasis is an immune-mediated chronic inflammatory skin disease and chronic kidney disease is one of the common comorbidities of psoriasis. Ixekizumab, a humanized IgG4 monoclonal antibody, has been approved for the treatment of moderate-to-severe plaque psoriasis in recent years. However, ixekizumab has not been studied in a population of patients with renal insufficiency. We report two cases of plaque psoriasis patients with renal dysfunction successfully treated with ixekizumab without dose reduction,which experience no side effects and does not cause further kidney injury.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the effectiveness of a blended video plus face-to-face educational program with a face-to-face educational program on quality of life among adolescents undergoing hemodialysis in Palestine. 比较混合视频加面对面教育计划与面对面教育计划对巴勒斯坦接受血液透析的青少年生活质量的影响。
Nawras Fashafsheh, Ping Lei Chui, Mahmoud Danaee, Ahmad Ayed, Lee Lee Lai

Introduction: Hemodialysis is frequently used as a primary treatment for individuals with end-stage kidney disease (ESKD), and it significantly impacts the quality of life in adolescents undergoing this procedure. Providing a hemodialysis education to these patients is a valuable strategy for enhancing their well-being. The aim of the study is to assess the effect of the video-assisted educational program on the quality of life among adolescents undergoing hemodialysis in Palestine.

Methods: This study employed a quasi-experimental design, a pre-test-post-test interventional study, involving a sample of 68 adolescent patients between the ages of 13 and 18 diagnosed with ESKD. The quality of life level was assessed in both groups using an Arabic version of the Pediatric Quality of Life Inventory™ version 3.0 ESKD Module survey. The study was conducted at the dialysis units in four hospitals associated with Augusta Victoria Hospital, An-Najah University Hospital, Palestine Medical Complex/Ramallah, and Beit Jala (Al Housain) Hospital. The study involved providing tailored face-to-face educational sessions with video assistance to the experimental group, while the control group received regular face-to-face education.

Findings: The Generalized Estimating Equation analysis revealed no significant differences in quality of life between the experimental and control groups over time, across pre-test, post-test, and follow-up periods (p ≥ 0.05). However, within the experimental group, there was a significant improvement in total quality of life scores between the pre-test, post-test, and post-test follow-up (p ≤ 0.001), although the difference between the pre-test and follow-up approached significance but was not statistically significant (p = 0.056). In contrast, the control group showed significant differences in quality of life across the pre-test, post-test, and follow-up time points (p ≤ 0.05).

Discussion: Implementing suitable interventions can potentially enhance the quality of life for individuals undergoing hemodialysis. Consequently, we suggest using video-based education as a cost-effective, uncomplicated, and engaging approach for educating hemodialysis patients.

简介:血液透析是终末期肾病(ESKD)患者常用的一种主要治疗方法,对接受血液透析的青少年的生活质量有很大影响。为这些患者提供血液透析教育是提高他们生活质量的重要策略。本研究旨在评估视频辅助教育计划对巴勒斯坦接受血液透析的青少年生活质量的影响:本研究采用了准实验设计,是一项前测-后测的干预性研究,涉及 68 名年龄在 13 至 18 岁之间、被诊断为 ESKD 的青少年患者。使用阿拉伯语版儿科生活质量量表™ 3.0 ESKD 模块调查对两组患者的生活质量水平进行了评估。该研究在奥古斯塔维多利亚医院、安纳贾大学医院、巴勒斯坦医疗中心/拉马拉医院和拜特贾拉(Al Housain)医院等四家医院的透析室进行。研究内容包括为实验组提供量身定制的面对面教育课程和视频协助,而对照组则接受常规的面对面教育:广义估计方程分析表明,实验组和对照组的生活质量在测试前、测试后和随访期间没有显著差异(p ≥ 0.05)。然而,在实验组中,生活质量总分在测试前、测试后和测试后随访期间有显著改善(p ≤ 0.001),尽管测试前和随访期间的差异接近显著,但在统计学上并不显著(p = 0.056)。相比之下,对照组在测试前、测试后和随访时间点上的生活质量差异显著(p ≤ 0.05):讨论:实施适当的干预措施有可能提高血液透析患者的生活质量。因此,我们建议使用基于视频的教育方法对血液透析患者进行教育,这种方法成本低廉、操作简单且极具吸引力。
{"title":"Comparing the effectiveness of a blended video plus face-to-face educational program with a face-to-face educational program on quality of life among adolescents undergoing hemodialysis in Palestine.","authors":"Nawras Fashafsheh, Ping Lei Chui, Mahmoud Danaee, Ahmad Ayed, Lee Lee Lai","doi":"10.1111/hdi.13182","DOIUrl":"https://doi.org/10.1111/hdi.13182","url":null,"abstract":"<p><strong>Introduction: </strong>Hemodialysis is frequently used as a primary treatment for individuals with end-stage kidney disease (ESKD), and it significantly impacts the quality of life in adolescents undergoing this procedure. Providing a hemodialysis education to these patients is a valuable strategy for enhancing their well-being. The aim of the study is to assess the effect of the video-assisted educational program on the quality of life among adolescents undergoing hemodialysis in Palestine.</p><p><strong>Methods: </strong>This study employed a quasi-experimental design, a pre-test-post-test interventional study, involving a sample of 68 adolescent patients between the ages of 13 and 18 diagnosed with ESKD. The quality of life level was assessed in both groups using an Arabic version of the Pediatric Quality of Life Inventory™ version 3.0 ESKD Module survey. The study was conducted at the dialysis units in four hospitals associated with Augusta Victoria Hospital, An-Najah University Hospital, Palestine Medical Complex/Ramallah, and Beit Jala (Al Housain) Hospital. The study involved providing tailored face-to-face educational sessions with video assistance to the experimental group, while the control group received regular face-to-face education.</p><p><strong>Findings: </strong>The Generalized Estimating Equation analysis revealed no significant differences in quality of life between the experimental and control groups over time, across pre-test, post-test, and follow-up periods (p ≥ 0.05). However, within the experimental group, there was a significant improvement in total quality of life scores between the pre-test, post-test, and post-test follow-up (p ≤ 0.001), although the difference between the pre-test and follow-up approached significance but was not statistically significant (p = 0.056). In contrast, the control group showed significant differences in quality of life across the pre-test, post-test, and follow-up time points (p ≤ 0.05).</p><p><strong>Discussion: </strong>Implementing suitable interventions can potentially enhance the quality of life for individuals undergoing hemodialysis. Consequently, we suggest using video-based education as a cost-effective, uncomplicated, and engaging approach for educating hemodialysis patients.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features associated with arteriovenous fistula patency. A meta-analysis. 与动静脉瘘通畅相关的特征。荟萃分析。
Dongjuan Zhang, Jing Liang, Yang Yang

Introduction: It is unclear if cannulation-associated variables such as timing of first cannulation, access creation method, cannulation technique, or needle type are associated with the outcomes of arteriovenous fistulas. We conducted a meta-analysis to investigate such potential associations with 1-year primary patency.

Methods: Twenty-eight publications with titles that included "arteriovenous fistula," "patency," "cannulation," "metric," "first cannulation," "hemodialysis," "complication," "vascular," "nursing," and "puncture" were retrieved and reviewed.

Findings: The 1-year primary patency rates ranged from 0.32 to 0.93. Primary patency rates were significantly lower in patients in whom initial cannulation was done less than 1.5 months after fistula creation compared to fistulas first cannulated more than 1.5 months after anastomosis (odds ratio [OR] = 0.41, 95% confidence interval [CI]: 0.32-0.52). The effect of cannulation timing on primary patency rate was attenuated when plastic cannulas were used during the first two to three puncture weeks compared to metal needles (OR = 0.62 vs. 0.34; p = 0.032). Fistulas in the upper arm did not have a higher 1-year primary patency compared to those in the forearm (OR = 1.05, 95% CI: 0.93-1.19). Primary patency of upper arm arteriovenous fistulas was higher in reports from the Americas or Europe compared to reports from Asia. Buttonhole cannulation was not associated with higher patency rates at 1 year compared to rope-ladder cannulation (OR = 1.14, 95% CI: 0.75-1.71).

Discussion: Early cannulation was associated with reduced 1-year arteriovenous fistula patency. This association was reduced when plastic cannulas were used during the initial 2-3 weeks.

导言:目前尚不清楚首次插管的时间、建立通路的方法、插管技术或针头类型等插管相关变量是否与动静脉瘘的预后有关。我们进行了一项荟萃分析,以研究这些变量与 1 年主要通畅率之间的潜在关联:我们检索并审查了标题中包含 "动静脉瘘"、"通畅"、"插管"、"计量"、"首次插管"、"血液透析"、"并发症"、"血管"、"护理 "和 "穿刺 "的 28 篇文献:1 年初次通畅率从 0.32 到 0.93 不等。与吻合术后 1.5 个月以上首次插管的瘘管相比,瘘管建立后 1.5 个月以内首次插管的患者的初次通畅率明显较低(几率比 [OR] = 0.41,95% 置信区间 [CI]:0.32-0.52)。与金属针相比,在最初两到三个穿刺周内使用塑料插管时,插管时间对初次通畅率的影响会减弱(OR = 0.62 vs. 0.34; p = 0.032)。与前臂瘘管相比,上臂瘘管的 1 年初次通畅率并不更高(OR = 1.05,95% CI:0.93-1.19)。与亚洲的报告相比,美洲或欧洲的报告中上臂动静脉瘘的初次通畅率更高。与绳梯插管相比,扣眼插管与更高的1年通畅率无关(OR = 1.14,95% CI:0.75-1.71):讨论:早期插管与动静脉瘘1年通畅率降低有关。讨论:早期插管与 1 年动静脉瘘通畅率降低有关,在最初 2-3 周使用塑料插管时,这种关联性降低。
{"title":"Features associated with arteriovenous fistula patency. A meta-analysis.","authors":"Dongjuan Zhang, Jing Liang, Yang Yang","doi":"10.1111/hdi.13183","DOIUrl":"https://doi.org/10.1111/hdi.13183","url":null,"abstract":"<p><strong>Introduction: </strong>It is unclear if cannulation-associated variables such as timing of first cannulation, access creation method, cannulation technique, or needle type are associated with the outcomes of arteriovenous fistulas. We conducted a meta-analysis to investigate such potential associations with 1-year primary patency.</p><p><strong>Methods: </strong>Twenty-eight publications with titles that included \"arteriovenous fistula,\" \"patency,\" \"cannulation,\" \"metric,\" \"first cannulation,\" \"hemodialysis,\" \"complication,\" \"vascular,\" \"nursing,\" and \"puncture\" were retrieved and reviewed.</p><p><strong>Findings: </strong>The 1-year primary patency rates ranged from 0.32 to 0.93. Primary patency rates were significantly lower in patients in whom initial cannulation was done less than 1.5 months after fistula creation compared to fistulas first cannulated more than 1.5 months after anastomosis (odds ratio [OR] = 0.41, 95% confidence interval [CI]: 0.32-0.52). The effect of cannulation timing on primary patency rate was attenuated when plastic cannulas were used during the first two to three puncture weeks compared to metal needles (OR = 0.62 vs. 0.34; p = 0.032). Fistulas in the upper arm did not have a higher 1-year primary patency compared to those in the forearm (OR = 1.05, 95% CI: 0.93-1.19). Primary patency of upper arm arteriovenous fistulas was higher in reports from the Americas or Europe compared to reports from Asia. Buttonhole cannulation was not associated with higher patency rates at 1 year compared to rope-ladder cannulation (OR = 1.14, 95% CI: 0.75-1.71).</p><p><strong>Discussion: </strong>Early cannulation was associated with reduced 1-year arteriovenous fistula patency. This association was reduced when plastic cannulas were used during the initial 2-3 weeks.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hemodialysis international. International Symposium on Home Hemodialysis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1